|
|
Volumn 27, Issue 12, 2009, Pages 1070-
|
|
Proteostasis Therapeutics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CALCIUM;
CENTRAL NERVOUS SYSTEM AGENTS;
CHAPERONE;
FX 1006A;
HEAT SHOCK PROTEIN 70;
MUTANT PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
POLYGLUTAMINE;
PREALBUMIN;
PROTEIN;
SOMATOMEDIN;
TAFAMADIS MEGLUMINE;
UNCLASSIFIED DRUG;
AGING;
ALZHEIMER DISEASE;
AMYLOID NEUROPATHY;
BIOLOGY;
CALCIUM CELL LEVEL;
CANCER RISK;
CELL MIGRATION;
CHEMISTRY;
CLINICAL TRIAL;
DEGENERATIVE DISEASE;
ENDOPLASMIC RETICULUM;
FABRY DISEASE;
FINANCIAL MANAGEMENT;
FUNDING;
GAUCHER DISEASE;
GENETICS;
HEAT SHOCK RESPONSE;
HOMEOSTASIS;
HUMAN;
HUNTINGTON CHOREA;
LIFESPAN;
LONGEVITY;
LYSOSOME STORAGE DISEASE;
MITOCHONDRION;
NERVE DEGENERATION;
NOTE;
PARKINSON DISEASE;
PRIORITY JOURNAL;
PROTEIN AGGREGATION;
PROTEIN ASSEMBLY;
PROTEIN FOLDING;
PROTEIN MISFOLDING;
PROTEOSTASIS;
TRANSTHYRETIN AMYLOID POLYNEUROPATHY;
UNITED STATES;
VIRUS INFECTION;
BIOTECHNOLOGY;
HUMANS;
INDUSTRY;
MASSACHUSETTS;
PROTEOSTASIS DEFICIENCIES;
|
|
EID: 71849091749
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt1209-1070 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
